The recent study shows that NCI/ADR-RES cells are derived from OVCAR-8 ovarian adenocarcinoma cells. The multidrug-resistant MCF-7 breast adenocarcinoma cells originally named MCF-7/AdrR cells and later re-designated NCI/ADR-RES have served as an important and widely used research tool during the last two decades. The case of NCI/ADR-RES cells highlights a wide-spread problem of cell line cross-contamination and misidentification. (BRENDA Tissue and Enzyme Source Ontology, BTO_0004181)
Downloads & Tools
5 proteins co-occuring with the tissue nci/adr-res cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.